Epidermolysis Bullosa Simplex
📧 Sign up to get email alerts when something new happens for Epidermolysis Bullosa Simplex.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-09-11Clinical Trial Update: A Phase II, Placebo Controlled, Clinical Trial of Topical TolaSure Targeting Aggregated Mutant Keratin in Epidermolysis Bullosa Simplex [Phase 2]
Phase II placebo-controlled trial evaluating Topical TolaSure for aggregated mutant keratin in Epidermolysis Bullosa Simplex; currently recr…
-
CLINICAL_TRIALS research · 2025-08-05Clinical Trial Update: A 44-week Monocentric Open Study Assessing the Efficacy and Safety of Deucravacitinib in Adults With Inflammatory Genodermatoses [Phase 2]
Phase 2 monocentric trial evaluating the efficacy and safety of deucravacitinib in adults with inflammatory genodermatoses; currently recrui…
-
CLINICAL_TRIALS research · 2015-06-12Clinical Trial Update: Diacerin for the Treatment of Epidermolysis Bullosa Simplex [Phase 2]
This document reports a Phase 2 clinical trial evaluating Diacerin for Epidermolysis Bullosa Simplex, with the current trial status listed a…
-
CLINICAL_TRIALS research · 2011-03-09Clinical Trial Update: Botulinumtoxin A Treatment in Epidermolysis Bullosa Simplex and Pachyonychia Congenita [Phase 2]
Phase 2 clinical trial update on Botulinumtoxin A for Epidermolysis Bullosa Simplex and Pachyonychia Congenita; sponsor is Uppsala Universit…